The Gross Margin of Carna Biosciences Inc (4572.T) is 73.20%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 73.20% |
| 2023-12-31 | 89.22% |
| 2022-12-31 | 87.63% |
| 2021-12-31 | 93.29% |
| 2020-12-31 | 83.05% |
| 2019-12-31 | 93.53% |
| 2018-12-31 | 66.78% |
| 2017-12-31 | 66.16% |
| 2016-12-31 | 68.65% |
| 2015-12-31 | 82.82% |